The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_001033855.3(DCLRE1C):c.241C>T (p.Arg81Ter)

CA117001

4665 (ClinVar)

Gene: DCLRE1C
Condition: severe combined immunodeficiency due to DCLRE1C deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: e3e1b71b-a5f7-46e8-ac26-4ef03d6cc5c5
Approved on: 2024-01-23
Published on: 2024-01-23

HGVS expressions

NM_001033855.3:c.241C>T
NM_001033855.3(DCLRE1C):c.241C>T (p.Arg81Ter)
NC_000010.11:g.14945110G>A
CM000672.2:g.14945110G>A
NC_000010.10:g.14987109G>A
CM000672.1:g.14987109G>A
NC_000010.9:g.15027115G>A
NG_007276.1:g.13986C>T
ENST00000378278.7:c.241C>T
ENST00000357717.6:c.-44+3926C>T
ENST00000378241.5:c.-247C>T
ENST00000378246.6:c.-49C>T
ENST00000378249.5:c.-49C>T
ENST00000378254.5:c.-120C>T
ENST00000378255.5:c.-442C>T
ENST00000378258.5:c.-120C>T
ENST00000378278.6:c.241C>T
ENST00000378289.8:c.241C>T
ENST00000396817.6:c.-442C>T
ENST00000418843.5:c.-157C>T
ENST00000456122.1:c.-371C>T
NM_001033855.2:c.241C>T
NM_001033857.2:c.-120C>T
NM_001033858.2:c.-442C>T
NM_001289076.1:c.-44+3926C>T
NM_001289077.1:c.-120C>T
NM_001289078.1:c.-49C>T
NM_001289079.1:c.-442C>T
NM_022487.3:c.-49C>T
NR_110297.1:n.748C>T
NM_001350965.1:c.241C>T
NM_001350966.1:c.-49C>T
NM_001350967.1:c.-120C>T
NR_146960.1:n.663C>T
NR_146961.1:n.748C>T
NR_146962.1:n.663C>T
NM_001033857.3:c.-120C>T
NM_001033858.3:c.-442C>T
NM_001289076.2:c.-44+3926C>T
NM_001289077.2:c.-120C>T
NM_001289078.2:c.-49C>T
NM_001289079.2:c.-442C>T
NM_001350965.2:c.241C>T
NM_001350966.2:c.-49C>T
NM_001350967.2:c.-120C>T
NM_022487.4:c.-49C>T
NR_110297.2:n.412C>T
NR_146961.2:n.412C>T
More

Pathogenic

Met criteria codes 5
PM2_Supporting PP4 PS3_Moderate PVS1 PM3_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DCLRE1C Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The NM_001033855.3:c.241C>T (p.Arg81Ter) variant in DCLRE1C is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon, 3/14, which is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The filtering allele frequency (the upper threshold of the 95% CI of 38/1177816 alleles) of the c.241C>T variant in DCLRE1C is 0.00002205 for European (non-Finnish) chromosomes by gnomAD v4, which is lower than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). Activity levels in % of WT activity = Recombination: Mean (SD): 19.48 (1.56) and DNA repair (36h after IR): Mean (SD): 16.05 (4.77). Both values are lower than our established threshold for abnormal results (defined as <25% of wild-type activity). Thus, PS3 is Met at a moderate level. (PMID: 25917813). At least one patient with this variant displayed Diagnostic criteria for SCID/Leaky SCID/Omenn syndrome 0.5pts + T-B-NK+ lymphocyte subset profile 0.5pts; the total is 1 point, which is highly specific for SCID (PP4_Supporting, PMID: 11336668). The proband (P2) is homozygous (Table 1) for this variant (0.5pt; PM3_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive severe combined immunodeficiency due to DCLRE1C deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PVS1, PM2_Supporting, PM3_Supporting, PS3_Moderate, and PP4_Supporting (VCEP specifications version 1).
Met criteria codes
PM2_Supporting
The filtering allele frequency (the upper threshold of the 95% CI of 38/1177816 alleles) of the c.241C>T variant in DCLRE1C is 0.00002205 for European (non-Finnish) chromosomes by gnomAD v4, which is lower than the ClinGen SCID VCEP threshold (<0.00003266) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting).
PP4
At least one patient with this variant displayed Diagnostic criteria for SCID/Leaky SCID/Omenn syndrome 0.5pts + T-B-NK+ lymphocyte subset profile 0.5pts; the total is 1 point, which is highly specific for SCID (PP4_Supporting, PMID: 11336668).
PS3_Moderate
Activity levels in % of WT activity = Recombination: Mean (SD): 19.48 (1.56) and DNA repair (36h after IR): Mean (SD): 16.05 (4.77). Both values are lower than our established threshold for abnormal results (defined as <25% of wild-type activity). Thus, PS3 is Met at a moderate level. (PMID: 25917813).
PVS1
The NM_001033855.3:c.241C>T (p.Arg81Ter) variant in DCLRE1C is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon, 3/14, which is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PM3_Supporting
One proband (P2) is homozygous (Table 1) for this variant (0.5pt; PM3_Supporting). PMID: 11336668
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.